<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國(guó)服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028012Irbinitinib 937263-43-9

    Irbinitinib 937263-43-9

    簡(jiǎn)要描述:Irbinitinib 937263-43-9
    Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.

    • 產(chǎn)品型號(hào):abs47028012
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-13
    • 訪  問  量:956

    詳細(xì)介紹

    品牌absinCAS937263-43-9
    分子式C26H24N8O2純度98%
    分子量480.52貨號(hào)abs47028012
    規(guī)格10mg供貨周期現(xiàn)貨
    主要用途is a potent and selective HER2 inhibitor應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Irbinitinib 937263-43-9

    產(chǎn)品描述
    描述
    Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.
    純度
    98%
    儲(chǔ)存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    可溶性/溶解性
    10 mM in DMSO
    生物活性
    靶點(diǎn)
    p95 HER2 ,ErbB2
    In vitro(體外研究)
    The compound is a reversible, ATP-competitive inhibitor with nanomolar potency against ErbB2 in both in vitro and in cell-based assays. Incell-based assays, ARRY-380 is ~500-fold selective for HER2 vs. EGFR and is equipotent against truncated p95-HER2.
    In vivo(體內(nèi)研究)
    In vivo, ARRY-380 significantly inhibits tumor growth in multiple HER2-dependent tumor xenograft models. It shows excellent activity in numerous mouse tumor models including breast (BT-474, MDA-MB-453), ovarian (SKOV-3) and gastric (N87) carcinoma models. In the BT-474 model, ARRY-380 demonstrated significant dose-related tumor growth inhibition (TGI; 50% at 50 mg/kg/d and 96% at 100 mg/kg/d) with numerous partial regressions (>50% reduction from baseline size).
    參考文獻(xiàn)
    參考文獻(xiàn)
    研究領(lǐng)域
    研究領(lǐng)域
    CancerTumor biomarkersOncoproteins
    CancerTumor immunologyTumor-associated antigens
    NeuroscienceDevelopment
    Signal TransductionProtein PhosphorylationTyrosine KinasesReceptor Tyrosine Kinases
    Tags & Cell MarkersCell Type MarkersTumor Associated
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Irbinitinib 937263-43-9溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說明:

    • 驗(yàn)證碼:

      請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
    歡迎您關(guān)注我們的微信公眾號(hào)
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    性爱视频网站免费 | 人人射综合网 | 波多野结衣天堂 | 乱╳╳╳AⅤ | 豆花视频一区二区 |